1. Home
  2. JBLU vs EVO Comparison

JBLU vs EVO Comparison

Compare JBLU & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$5.14

Market Cap

1.5B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.63

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBLU
EVO
Founded
1998
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
JBLU
EVO
Price
$5.14
$3.63
Analyst Decision
Sell
Strong Buy
Analyst Count
9
1
Target Price
$4.76
$7.00
AVG Volume (30 Days)
17.7M
255.2K
Earning Date
01-27-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,095,000,000.00
$887,396,457.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.18
$8.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$2.84
52 Week High
$8.31
$4.80

Technical Indicators

Market Signals
Indicator
JBLU
EVO
Relative Strength Index (RSI) 63.48 70.78
Support Level $4.51 $3.10
Resistance Level $5.20 $3.23
Average True Range (ATR) 0.18 0.08
MACD 0.02 0.07
Stochastic Oscillator 85.00 96.84

Price Performance

Historical Comparison
JBLU
EVO

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: